Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.78
-0.02 (-0.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
88
Market Cap
2.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BrightSpring Health Services | 10.59B |
QuidelOrtho | 2.82B |
ACADIA Pharmaceuticals | 929.24M |
iRhythm Technologies | 560.03M |
Amicus Therapeutics | 493.67M |
Zai Lab | 355.75M |
Twist Bioscience | 312.97M |
Merus | 35.93M |
EWTX News
- 5 days ago - Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease - Benzinga
- 5 days ago - Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker) - Business Wire
- 16 days ago - Edgewise Provides Statement Regarding Company's Relationship with Dr. Han Phan at Rare Disease Research - Business Wire
- 25 days ago - Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 - Business Wire
- 6 weeks ago - Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society - Business Wire
- 2 months ago - Analysts Think There's Still Time To Get In On Edgewise - Benzinga
- 3 months ago - Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - Benzinga